and taraviras@med. upatras.gr T he interplay of proliferation and differentiation is essential for normal development and organogenesis. Geminin is a cell cycle regulator which controls licensing of origins for DNA replication, safeguarding genomic stability. Geminin has also been shown to regulate cellular decisions of selfrenewal versus commitment of neuronal progenitor cells. We discuss here our recent analysis of mice with conditional inactivation of the Geminin gene in the immune system. Our data indicate that Geminin is not indispensable for every cell division: in the absence of Geminin, development of progenitor T-cells appears largely unaffected. In contrast, rapid cell divisions, taking place in vitro upon TCR receptor activation or in vivo during homeostatic proliferation, are defective.
The development of multicellular organisms requires the generation of numerous specialized cells organized in a structure necessary for function. The acquisition of specialized function takes place progressively. During embryogenesis, tissue stem and progenitor cells are undergoing several rounds of division before they adopt a non-dividing differentiated phenotype. Therefore self-renewal and differentiation of stem/progenitor cells should be coordinated to meet criteria set by the function and the size constraints of the developing organ. During development, diffusible factors and membrane receptors influence
Life without Geminin
Dimitris Karamitros, l Panorea Kotantaki, l Zoi Lygerou, 2 Henrique Veiga-Fernandes, 3, 4 Vassilis Pachnis, 5 A number of studies over the past 10 years have shed more light into the function of Geminin at the molecular level and have suggested that Geminin may coordinate proliferation and differentiation decisions through direct interactions with multiple binding partners. [3] [4] [5] Geminin, a small coiled-coil protein present in metazoa, inhibits licensing of origins for DNA replication through binding and inhibiting Cdtl, a key member of the pre-replicative complex. [6] [7] [8] Geminin binding to Cdt1 during the S and G 2 phases of the cell cycle inhibits re-replication of origins that have already fired, thereby ensuring once per cell cycle replication and genome stability.
9-11 Consistent with its role as a central cell cycle regulator, Geminin depletion results in genome over-replication, DNA damage and G 2 /M cell cycle arrest [12] [13] [14] [15] [16] while Geminin overexpression causes G 1 /S arrest or leads to apoptosis. Different cell types however cell mass. 24, 25 Trophoblast giant cells are present, suggesting a role for Geminin in the establishment of pluripotency. 24 Morpholino experiments in Xenopus have shown that reduced Geminin expression leads to cell cycle arrest and embryonic lethality in high doses, while intermediate doses led to downregulation of neural fate markers in a significant percentage of embryos, suggesting that Geminin is required for the acquisition and maintenance of neural fate. 12, 19 Similar experiments in Medaka revealed optic vesicle enlargement due to increased proliferation. 21 While the above experiments have contributed towards our understanding of Geminin's functions, the early lethality associated with a complete Geminin knock-out during embryogenesis hinders an understanding of its role at specific tissues and specific stages during development and homeostasis.
In Medaka, Geminin has been shown to bind the transcription factor Six3 and antagonize its pro-differentiation function during eye organogenesis. 21 Geminin also binds to Hox family members while in addition it regulates expression of the Hox genes through Polycomb-mediated interaction. 22 Geminin's role has also been expanded to non-neuronal tissues, as it has been proposed to be involved in maintaining hematopoietic stem cells. 23 These lines of work indicate that Geminin interacts with a number of transcription factors and chromatin remodelling activities and regulates transcriptional programs, thereby affecting cell-fate decisions (Fig. 1) .
Geminin knock-down experiments at the level of the organism are supportive of a central role for Geminin as a regulator of proliferation and differentiation. In the mouse, Geminin-deficient embryos die at the 8 cell stage and fail to form an inner differ in their response to Geminin depletion or overexpression, with cancer cells appearing more sensitive than normal human cells to both Geminin overexpression and knock-down. 17, 18 The role of Geminin as a regulator of differentiation and cell fate decisions remains less well understood. During Xenopus early development, Geminin has been shown to bind Brg1 and Brahma (Brm), the catalytic subunits of the chromatin remodelling complex SWI/SNF, and compete with basic helix-loop-helix transcription factors, thereby maintaining neural progenitor cells in an undifferentiated state. 19 During neural plate development, Geminin has been shown to regulate Sox2 expression, the earliest definitive marker for the neural plate, through interactions with the chromatin remodelling factor Brm and two novel coiledcoil proteins named ERNI and BERT. progression and accumulation in S/G 2 /M with increased protein levels of cyclin B1, cyclin A and tyrosine 15 phosphorylated cdc2. In addition, the number of cells exiting the cell cycle following an attempt to replicate is increased. Similarly, following transfer to a lymphopenic recipient in vivo, Geminin deficient T cells are unable to efficiently proliferate and repopulate the host, showing that Geminin is essential for efficient homeostatic expansion of peripheral T cells (Fig. 2) .
These results are supporting the idea that Geminin is an essential cell cycle regulator in certain cells but may be dispensable for cell cycle progression in others. Geminin therefore joins other central cell cycle regulators, such as cdk2, cyclin E and cyclin A, which were unexpectedly shown to be dispensable for cell proliferation, while being required in certain cell types and for certain processes.
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Geminin, a Redundant Mechanism for Cdt1 Regulation and Maintenance of Genomic Stability
Our findings for a differential requirement for Geminin in developing thymocytes versus activated peripheral T cells are reminiscent of Geminin depletion experiments in cultured human cells, where DNA re-replication was induced in some cell lines 14, 15, 24, 25, 30 and not in others. 18, [31] [32] [33] Why do different cells show a differential requirement for Geminin for normal cell cycle progression? The critical role of Geminin during the cell cycle is believed to be the inhibition of untimely licensing by restricting the activity of Cdt1. The relative expression levels of Cdtl and Geminin might render a particular cell type more sensitive to alterations in the expression of one of the two partners. Consistently, the effects of Cdt1 overexpression also differ between different cell types. 15, [34] [35] [36] In support of this notion, Cdtl protein expression levels in stimulated peripheral T cells that lack Geminin expression is increased compared to the wild-type control, while thymocytes in the absence of Geminin show reduced expression of the Cdtl protein. 26 Therefore, the increased sensitivity of peripheral T cells to the absence of Geminin could be attributed (DNl), DN4 and DP T cells were observed (Fig. 2) . These data suggest that proliferation and differentiation events associated with T-cell development progress apparently normally in the absence of Geminin. Unpublished observations from our lab indicate that normal development in the absence of Geminin is not a peculiarity of the T-cell compartment: B cell and hepatocyte development also progress apparently unaffected by the absence of Geminin. These findings are challenging our current view of Geminin as indispensible for cell proliferation and differentiation.
In contrast to thymic cell populations, peripheral T-cell populations such as naive, memory and regulatory T cells show a significant reduction in the absence of Geminin. Importantly, mature peripheral T-cells lacking Geminin exhibit significant defects in proliferation both in vitro and in vivo. Following T-cell receptor (TCR) stimulation in vitro, normal peripheral T cells enter the cell cycle and rapidly proliferate, mimicking the activation of peripheral T cells upon infection. Geminin deficient peripheral T cells however show marked cell cycle defects upon TCR stimulation: reduced cell cycle
Conditional Inactivation of Geminin in the Mouse Immune System
In order to extend our understanding in the in vivo role of Geminin in regulating progenitor cell self-renewal and differentiation decisions in different cellular systems, we have generated mice that allow the conditional inactivation of the mouse Geminin gene, overcoming the lethality observed during the early steps of mouse embryogenesis of constitutive mutants. 26 In these mice, exons 3 and 4 of the Geminin gene are flanked by loxP sites, allowing conditional deletion in cells expressing the Cre recombinase. In order to address Geminin's role in the lymphoid system, Geminin loxP mice were crossed to a transgenic mouse line where Cre expression is under the control of the promoter and Locus Control Region of the human CD2 gene. Unexpectedly, Geminin deficiency does not alter development and differentiation of T cells in vivo. Our analysis shows that Geminin-deficient progenitor T-cell populations of the thymus are able to generate all the thymic cell subpopulations and only minor reductions in absolute numbers of double negative l Figure 2 . Differential requirements for Geminin in t cells. in the lymphoid system, commitment and differentiation processes of the t-cell lineage in the thymus proceed normally in the absence of Geminin. However, Geminin is required for the proliferation of t cells that take place either in vitro upon tCr receptor activation or in vivo during homeostatic expansion.
Could the rate of cell proliferation affect a cell's requirement for Geminin? Licensing of replication origins is established during G 1 through pre-replicative complex formation, during which MCM proteins associate with chromatin on origins of replication. Rapid cell divisions require licensing to take place in a shorter time, due to the short duration of the G 1 phase. Rapidly dividing cells may also need to license a greater number of origins in order to replicate their DNA efficiently. Geminin inhibition of untimely licensing may be more critical under these conditions. During differentiation, the timing of replication of different genomic regions is altered as transcriptional profiles change, while chromatin organization and subnuclear locations are also changing in a coordinate fashion. 48, 49 Interactions of Geminin with Polycomb group and chromatin remodeling SWI/SNF complexes might be essential in this transition to regulate pluripotency by repressing differentiation.
The differential requirements for cell cycle regulation, the redundant pathways regulating genomic integrity and the relative abundance of Geminin's interacting partners between different cell types may be critical in determining whether Geminin is required for cell proliferation and differentiation.
from those where Geminin function is redundant? In the absence of Geminin in the mouse, inner cell mass (ICM) cells are not formed, 24, 25 suggesting that Geminin is required for the generation of these cells from uncommitted totipotent embryonic stem cells. Pluripotent stem cells in the preimplantation mouse embryo and embryonic stem cells, which are equivalent to cells comprising the ICM, exhibit very fast cell cycles, lasting approximately 10 hours. [41] [42] [43] Rapid cell divisions in these cell types are characterized by a very short G 1 phase. 41, 43 As mESCs differentiate, cell cycle duration increases, mainly due to an increase in G 1 phase length. 43, 44 Rapid cell division also characterizes neural stem and progenitor cell populations, while an increase in the length of G 1 phase is linked with initiation of fate commitment and differentiation programs. 45 Peripheral lymphocytes also have unique properties in division: although mature T cells are quiescent they maintain a high capacity to self-renew to defend the organism from infection by exogenous pathogens. Activated T cells and T cells upon homeostatic proliferation will proliferate very rapidly. 46, 47 Similarly, cancer cells, which are more sensitive to Geminin depletion than normal cells, 18 show increased proliferation rates.
to an inability to regulate Cdtl expression levels upon Geminin reduction. In addition to Geminin inhibition, the activity of Cdt1 is controlled through cell cycle phase specific proteolysis mediated by two E3 ubiquitin ligase pathways, SCF Skp2 and CUL4Ddb1 Cdt2 , 37, 38 and these two pathways could compensate for Geminin loss in certain cell types or developmental stages. Furthermore, Cyclin A has been shown to act redundantly with Geminin to inhibit genome over-replication in certain cell types (Fig. 3) . 13, 32 Timely licensing is controlled at multiple levels and though the Cdt1/Geminin pair appears the critical target for regulation in metazoa, other components of the pre-replicative complex as well as Cyclin Dependent Kinase activity might contribute to the variable phenotypes observed upon Cdtl overexpression or Geminin inhibition in different cell types. The redundant regulation of multiple licensing factors may prevent the deleterious effects from deregulation of any individual factor alone. 39, 40 Cell Cycle Duration: A Critical Parameter for Geminin Function?
Are there any common traits that could differentiate cell cycles requiring Geminin Figure 3 . Geminin is one of several factors that regulate Cdt1 activity. the formation on origins of DNA replication of a multisubunit prereplicative complex consisting of OrC, Cdc6, Cdt1 and MCM proteins licences chromatin for replication. Cdt1 is essential for pre-replicative complex formation and it is regulated by multiple factors. Cdk-dependent phosphorylation and Skp2/ SCF-dependent ubiquitination targets Cdt1 for proteolysis. Cdt1 protein levels are also regulated by Cul4/Ddb1/PCNA. Geminin operates as a protein inhibitor through binding and inactivation of Cdt1. these pathways could be modified by extracellular signaling molecules and operate redundantly in order to regulate cell cycle progression and maintenance of genomic integrity. 50, 51 
